Detalhe da pesquisa
1.
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1.
Blood
; 136(25): 2851-2863, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-33113552
2.
Nivolumab and Doxorubicin, Vinblastine, and Dacarbazine in Early-Stage Unfavorable Hodgkin Lymphoma: Final Analysis of the Randomized German Hodgkin Study Group Phase II NIVAHL Trial.
J Clin Oncol
; 41(6): 1193-1199, 2023 02 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508302
3.
Efficacy of Nivolumab and AVD in Early-Stage Unfavorable Classic Hodgkin Lymphoma: The Randomized Phase 2 German Hodgkin Study Group NIVAHL Trial.
JAMA Oncol
; 6(6): 872-880, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32352505
4.
B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2.
Eur J Haematol
; 77(6): 539-41, 2006 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17105449